Studies Reporting Measurement of EDR-1m After Injection of 111In-Pentetreotide
| 111In-pentetreotide | Present study | Fayad et al. (11) | Morán et al. (14) | Kurtaran et al. (15) |
| Patients (n) | 12 | 6 | 2 | 16 |
| Injected activity (MBq) | ||||
| Mean ± SD | 170 ± 7 | 119 ± 67 | 140 ± 40 | |
| Range | 158–179 | 105–128 | 200–220 | |
| Time between injection and EDR-1m measurement (min) | 15 | |||
| Mean ± SD | 6.2 ± 5 | |||
| Range | 230–240 | 10–20 | ||
| Dose rate detector | PDS-100GN-ID | AT1123 (APVL Ingénierie) | MiniTRACE γ (Genitron) | LB 133 (Berthold Technologies) |
| EDR-1m from sternum (μSv/h) | 9.5 | |||
| Mean ± SD | 9.56 ± 0.93 | 5.5 ± 0.51 | 2.86 ± 1.22 | |
| Range | 8.50–11.0 | |||
| Median | 9.43 | |||
| EDR-1m from sternum per injected MBq (μSv/h/MBq) | NA | 43 | NA | |
| Mean ± SD | 54.3 ± 7.3 |
NA = not available.